Protocolo diagnóstico de la mastocitosis

  1. Armentia Medina, A. 1
  2. Martín Armentia, S. 2
  3. Fernández Cortés, S. 3
  1. 1 Unidades de Alergia, Hospital Universitario Río Hortega, Valladolid, España
  2. 2 Pediatría, Centro Delicias, Valladolid, España
  3. 3 Unidades de Asma Difícil, Hospital Universitario Río Hortega, Valladolid, España
Mostra les afiliacions +
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Any de publicació: 2021

Títol de l'exemplar: Enfermedades del sistema inmune (I)Enfermedades alérgicas

Sèrie: 13

Número: 28

Pàgines: 1593-1596

Tipus: Article

DOI: 10.1016/J.MED.2021.03.016 DIALNET GOOGLE SCHOLAR

Altres publicacions en: Medicine: Programa de Formación Médica Continuada Acreditado

Resum

Mastocytosis is an emerging differential diagnosis in patients with specific mediator-related symptoms. Typical skin lesions are found in some patients, and the mastocytosis diagnosis can be achieved. However, in absence of lesions, diagnosis is a challenge. We developed a diagnostic algorithm for patients with suspected mastocytosis based on international consensus of networks of experts on this disease.

Referències bibliogràfiques

  • Muñoz González JI, Álvarez Twose I, Jara Acebedo M, Hernriques A, Viñas E, Prieto C, Frequency and prognostic impact of KIT and other genetic variants in indolen systemic mastocytosis. Blood. 2019;134:456-68.
  • Sperr WR, Álvarez Twose I, van Anrooij B, Oude Elberink JNG, Gorska A, International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study. Lancet Haematol. 2019;6(12):e638-e649.
  • Barete S. A useful addon international prognostic score for mastocytosis? Lancet Haematol. 2019;6(12):e604-e605.
  • Armentia A, Pineda F, Fernández Cortés S, Moro A, Martín B, Méndez P, Mastocytosis and the fig wasp (Blastophafa psenes). Int Arch Allergy Immunol. 2019;178:291-4.
Fuente de los datos: Dialnet